Results 11 to 20 of about 26,800 (175)
African Journal of Emergency Medicine, 2011 The first cases of meningococcal meningitis were described in Geneva in 1805 and in New England in 1806, the causative agent finally being identified by Anton Weichselbaum in 1887.
Alex Koyfman, James Kimo Takayesu
doaj +4 more sources
Imaging of disease dynamics during meningococcal sepsis. [PDF]
PLoS ONE, 2007 Neisseria meningitidis is a human pathogen that causes septicemia and meningitis with high mortality. The disease progression is rapid and much remains unknown about the disease process. The understanding of disease development is crucial for development
Hong Sjölinder, Ann-Beth Jonsson
doaj +1 more source
Vaccines, 2020 This cross-sectional study assessed knowledge, attitudes, and practices regarding meningococcal disease and related vaccinations among healthcare workers (HCWs) who provided care to patients with underlying high-risk medical conditions.
Gabriella Di Giuseppe +3 more
doaj +1 more source
Fatal Nongroupable Neisseria meningitidis Disease in Vaccinated Patient Receiving Eculizumab
Emerging Infectious Diseases, 2018 Patients receiving eculizumab have an increased risk for meningococcal disease, but most reported cases are attributable to encapsulated meningococcal strains.
Deirdre Nolfi-Donegan +9 more
doaj +1 more source
Preventing invasive meningococcal disease in early infancy
Human Vaccines & Immunotherapeutics, 2022 This review considers the pathogenesis, diagnosis, and epidemiology of invasive meningococcal disease in infants, to examine and critique meningococcal disease prevention in this population through vaccination.
Jessica Presa +3 more
doaj +1 more source
BMJ Paediatrics Open, 2022 Background Aiming to the containment of the coronavirus disease 2019 (COVID-19) pandemic, governments worldwide have implemented a series of non-pharmaceutical interventions.
Theoklis Zaoutis +10 more
doaj +1 more source
Neurosciences, 2002 Meningococcal disease occurs as both endemic and epidemic disease in most parts of the world with significant morbidity and mortality. Among the different serogroups of Neisseria meningitidis, serogroups A, B, C account for 90% of the disease. In the last few years there has been a change in the epidemiology of the disease with an increase in the ...
Ziad A, Memish, Abdulrahman A, Alrajhi
openaire +3 more sources
Chemoenzymatic Synthesis of Well‐Defined α(2,8)‐ and α(2,9)‐Linked Oligosialosides
Angewandte Chemie, EarlyView.Well‐defined α(2,8)‐ and α(2,9)‐linked oligosialic acids of different lengths can be prepared by employing recombinant bacterial polysialyltransferases in combination with chemically modified CMP‐Neu5Ac derivatives. After transfer, a sialoside is formed bearing an artificial entity, which blocks further glycosylation.
Jelle A. Fok +4 more
wiley +2 more sources
Meningococcal Disease and Travel [PDF]
Clinical Infectious Diseases, 2002 Invasive meningococcal disease, in both endemic and epidemic forms, is the cause of significant morbidity and mortality worldwide. Despite all advances in therapy, the fatality rate of meningococcal meningitis remains unacceptably high, between 5% and 10%, and a similar proportion suffers long-term neurological sequalae.
openaire +2 more sources
Meningococcal vaccines in China
Human Vaccines & Immunotherapeutics, 2021 Meningococcal meningitis caused by Neisseria meningitidis is a reportable infectious disease in China, due to the high incidence of meningitis in the era before the availability of vaccines.
Yinghua Xu +5 more
doaj +1 more source